Novo Holdings establishes new firm managed by biotech veterans

Novo Holdings, the holdings company which owns Novo Nordisk, has founded a Danish private limited company named Aloop Therapeutics, with Orphazyme co-founder Thomas Kirkegaard Jensen as a director and Sandion Oncology CEO Bo Rode Hansen as chair of the board, according to a filing on the Danish Central Business Register (CVR).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings eyes opportunities as biotech bubble bursts
For subscribers